Indiana § 12-21-9-7 Application; clinical study requirements

Indiana Statutes

§ 12-21-9-7 — Application; clinical study requirements

Indiana § 12-21-9-7

Art. 21DIVISION OF MENTAL HEALTH AND

Ch. 9Therapeutic Psilocybin Research

This text of Indiana § 12-21-9-7 (Application; clinical study requirements) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 12-21-9-7 (2026).

Text

(a)A research institution in Indiana may apply to the division to receive financial assistance from the fund to conduct one (1) or more clinical studies to evaluate the efficacy of psilocybin and ibogaine as an alternative treatment for mental health and other medical conditions, including the following:

(1)Posttraumatic stress disorder, with a focus on treating the disorder in combat veterans and first responders.

(2)Anxiety.

(3)Depression.

(4)Bipolar disorder.

(5)Chronic pain.

(6)Migraines.

(7)Alcohol use disorder.

(8)Tobacco use disorder.

(b)In conducting a clinical study under this section, a research institution that receives a grant under this chapter shall do the following:

(1)Include veterans and first responders in the study sample.

(2)Evaluate and determine whether ps

Free access — add to your briefcase to read the full text and ask questions with AI

(a) A research institution in Indiana may apply
to the division to receive financial assistance from the fund to conduct
one (1) or more clinical studies to evaluate the efficacy of psilocybin
and ibogaine as an alternative treatment for mental health and other
medical conditions, including the following:
(1) Posttraumatic stress disorder, with a focus on treating the
disorder in combat veterans and first responders.
(2) Anxiety.
(3) Depression.
(4) Bipolar disorder.
(5) Chronic pain.
(6) Migraines.
(7) Alcohol use disorder.
(8) Tobacco use disorder.
(b) In conducting a clinical study under this section, a research
institution that receives a grant under this chapter shall do the
following:
(1) Include veterans and first responders in the study sample.
(2) Evaluate and determine whether psilocybin is an effective
treatment for mental health and other medical conditions
described in subsection (a).
(3) Compare the efficacy of psilocybin as a treatment for mental
health and other medical conditions described in subsection (a)
with the efficacy of other current treatment options for mental
health and other medical conditions described in subsection (a).
(4) Before entering the study, require each participant to undergo
a mental health evaluation.